Multimorbidity in Elderly Population: Challenges and Coping Strategies

Multimorbidity in Elderly Population: Challenges and Coping Strategies

Multimorbidity has become a prominent public health problem in older people in China as the country reached an aging society. Summarizing the studies in multimorbidity in elderly population and analyzing and discussing the coping strategies are of great significance for comprehensive management of t...

Full description

Bibliographic Details
Main Author:	ZHANG Yili, HUANG Xinyi, QI Baoyu, SUN Chuanrui, WANG Xiaoyang, WEI Xu, XIE Yanming
Format:	Article
Language:	zho
Published:	Chinese General Practice Publishing House Co., Ltd 2022-12-01
Series:	Zhongguo quanke yixue
Subjects:	comorbidity\|osteoporosis\|aged\|polypharmacy\|review
Online Access:	https://www.chinagp.net/fileup/1007-9572/PDF/zx20220514.pdf

Similar Items

Prevalence and Associated Factors of Lumbar Disc Herniation in Osteoporosis: a Cross-sectional Survey
by: HAN Tao, SUN Kai, SUN Chuanrui, ZHANG Yili, XIE Yanming, SHEN Hao, WANG Xu, QI Baoyu, ZHU Liguo, WEI Xu
Published: (2022-12-01)

Polypharmacy in Osteoporosis Patients
by: Yavuz Ali Karahan, et al.
Published: (2015-04-01)

Impact of Multimorbidity and Polypharmacy on Clinical Outcomes of Elderly Chinese Patients with Atrial Fibrillation
by: Agnieszka Kotalczyk, et al.
Published: (2022-03-01)

Impact of polypharmacy and comorbidity on survival and systemic parenteral treatment administration in a cohort of hospitalized lung-cancer patients
by: Hélène Pluchart, et al.
Published: (2023-06-01)

Chronic diseases spectrum and multimorbidity in elderly inpatients based on a 12-year epidemiological survey in China
by: Shan Gao, et al.
Published: (2024-02-01)

Drug-Induced Mitochondrial Toxicity in the Geriatric Population: Challenges and Future Directions
by: Yvonne Will, et al.
Published: (2019-05-01)

Polypharmacy and associated factors: a gender perspective in the elderly Spanish population (2011–2020)
by: Jesús Cebrino, et al.
Published: (2023-04-01)

Features of multimorbidity in elderly and senile people with hypertension
by: V. V. Popov, et al.
Published: (2021-05-01)

Incidence and risk factors for polypharmacy among elderly people assisted by primary health care in Brazil
by: Andréia Mascarelo, et al.
Published: (2023-08-01)

Comorbidities of Osteoporosis: Recent Advances and Early Screening
by: WEI Xu, LIU Ning, ZHANG Yili, HAN Tao, SUN Kai, QI Baoyu, CHEN Xin, QIN Xiaokuan, GAO Jinghua, XIE Yanming, ZHU Liguo
Published: (2022-12-01)

The work and the health of elderly butchers: case reports from a municipal market
by: Marcela Andrade Rios, et al.
Published: (2017-10-01)

Inappropriate Prescribing to Elderly Patients in an Internal Medicine Ward
by: Joana Urzal, et al.
Published: (2019-02-01)

Association of Vitamin D Level with Health-related Quality of Life in Community-dwelling Elderly Population
by: HUANG Xinyi, ZHANG Yili, SUN Kai, LIU Ning, QI Baoyu, GAO Jinghua, XIE Yanming, WEI Xu
Published: (2022-12-01)

Excessive Hypocoagulation in Therapy with Warfarin within Polypharmacy: Using online database Multi-Drug Interaction Checker and Graphic “Time-Effect-Drug Administration” to Eliminate Adverse Drug Event (Case Report)
by: G. S. Krasnov, et al.
Published: (2018-11-01)

Polypharmacy in the treatment of people diagnosed with borderline personality disorder: repeated cross-sectional study using New Zealand's national databases
by: Matthew Tennant, et al.
Published: (2023-11-01)

Optimising a person-centred approach to stopping medicines in older people with multimorbidity and polypharmacy using the DExTruS framework: a realist review
by: Amadea Turk, et al.
Published: (2022-08-01)

The Elderly’s Thoughts and Attitudes about Polypharmacy and Deprescribing: A Qualitative Pilot Study in Portugal
by: Pedro Simões, et al.
Published: (2022-11-01)

Evaluation of the Relationship Between Frailty and Polypharmacy in the Elderly Referred to the Emergency Departments of Ardabil, 2019
by: Hosein Asadi, et al.
Published: (2022-02-01)

Efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed people with HIV-1 aged ≥ 50 years: week 48 pooled results from the TANGO and SALSA studies
by: Sharon Walmsley, et al.
Published: (2024-03-01)

The association of parity number with multimorbidity and polypharmacy among Iranian women in the Azarcohort: a cross-sectional study
by: Elnaz Faramarzi, et al.
Published: (2023-06-01)

(In)Appropriate Prescription in the Elderly in Primary Health Care
by: Graça Cardoso, et al.
Published: (2022-09-01)

Incidence of Osteoporosis in Patients Admitted to our Physical Medicine and Rehabilitation Outpatient Clinics
by: Berat Meryem Alkan, et al.
Published: (2011-04-01)

Statin therapy in multimorbid older patients with polypharmacy- a cross-sectional analysis of the Swiss OPERAM trial population
by: Luise Adam, et al.
Published: (2023-09-01)

How to Improve Healthcare for Patients with Multimorbidity and Polypharmacy in Primary Care: A Pragmatic Cluster-Randomized Clinical Trial of the MULTIPAP Intervention
by: Isabel del Cura-González, et al.
Published: (2022-05-01)

Multimorbidity, polypharmacy and inappropriate prescribing in elderly patients with atrial fibrillation: A report from the China Atrial Fibrillation Registry Study
by: Xueyuan Guo, et al.
Published: (2022-09-01)

Multimorbidity and polypharmacy in hospitalized older patients: a cross-sectional study
by: Yong Zhao, et al.
Published: (2023-07-01)

Aging and the Prevalence of Polypharmacy and Hyper-Polypharmacy Among Older Adults in South Korea: A National Retrospective Study During 2010–2019
by: Ho Jin Cho, et al.
Published: (2022-05-01)

Influence of Multimorbidity on Anxiety Symptoms among Chinese Elderly People: a Propensity Score-matched Study
by: WANG Xiaoran, ZHANG Dan
Published: (2023-10-01)

Current Status of Polypharmacy in the Elderly and Its Influencing Factors: a Meta-analysis
by: XIE Xuemei, GAO Jing, BAI Dingxi, LU Xianying, HE Jiali, LI Yue
Published: (2023-12-01)

Polypharmacy in patients with multiple sclerosis and the impact on levels of care and therapy units
by: Finn Brüggemann, et al.
Published: (2023-12-01)

Lung cancer, comorbidities, and medication: the infernal trio
by: Hélène Pluchart, et al.
Published: (2024-02-01)

Depression and Anxiety in Association with Polypharmacy in Patients with Multiple Sclerosis
by: Julia Baldt, et al.
Published: (2023-08-01)

Selection of PPI in a comorbid patient with NSAIDgastroesophagopathy: case study
by: I. G. Pakhomova
Published: (2019-05-01)

Deprescribing medication in very elderly patients with multimorbidity: the view of Dutch GPs. A qualitative study
by: Schuling Jan, et al.
Published: (2012-07-01)

Risk of Polypharmacy and Its Outcome in Terms of Drug Interaction in an Elderly Population: A Retrospective Cross-Sectional Study
by: Reham M. Alhumaidi, et al.
Published: (2023-06-01)

Multimorbidity of Psoriasis: A Large-Scale Population Study of Its Associated Comorbidities
by: Manuel Almenara-Blasco, et al.
Published: (2024-01-01)

Polypharmacy Definitions for Multimorbid Older Adults Need Stronger Foundations to Guide Research, Clinical Practice and Public Health
by: Caroline Sirois, et al.
Published: (2019-08-01)

The Impact of Number of Medications on Falls in Aging Persons with Human Immunodeficiency Virus
by: Leanne W. Thai, et al.
Published: (2023-08-01)

Distribution of Traditional Chinese Medicine Constitution and Associated Factors of Yang-deficiency in Patients with Postmenopausal Osteoporosis in the Community
by: Chuanrui SUN, Yili ZHANG, Baoyu QI, Shengjie FANG, Tao HAN, Yanming XIE, Xu WEI, Liguo ZHU
Published: (2022-06-01)

The Challenge of Medication-Induced Dry Mouth in Residential Aged Care
by: William Murray Thomson, et al.
Published: (2021-10-01)